Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Arsenic Trioxide in Treating Patients With Pancreatic Cancer That Has Not Responded to Gemcitabine

ClinicalTrials.gov ID: NCT00053222

Public ClinicalTrials.gov record NCT00053222. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Study Of Arsenic Trioxide In Patients With Adenocarcinoma Of The Pancreas Refractory To Gemcitabine

Study identification

NCT ID
NCT00053222
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
University of Chicago
Other
Enrollment
13 participants

Conditions and interventions

Interventions

  • arsenic trioxide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2003
Primary completion
Dec 31, 2004
Completion
Jun 30, 2007
Last update posted
Sep 4, 2013

2003 – 2007

United States locations

U.S. sites
11
U.S. states
3
U.S. cities
11
Facility City State ZIP Site status
University of Chicago Cancer Research Center Chicago Illinois 60637-1470
Decatur Memorial Hospital Cancer Care Institute Decatur Illinois 62526
Evanston Northwestern Health Care - Evanston Hospital Evanston Illinois 60201-1781
Ingalls Memorial Hospital Harvey Illinois 60426
LaGrange Memorial Hospital LaGrange Illinois 60525
Loyola University Medical Center Maywood Illinois 60153
Oncology/Hematology Associates of Central Illinois, P.C. Peoria Illinois 61602
Central Illinois Hematology Oncology Center Springfield Illinois 62701
Fort Wayne Medical Oncology and Hematology, Incorporated Fort Wayne Indiana 46885-5099
CCOP - Northern Indiana CR Consortium South Bend Indiana 46601
Lakeland Cancer Care Center at Lakeland Hospital - St. Joseph Saint Joseph Michigan 49085

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00053222, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2013 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00053222 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →